Dyadic International Inc
DYAI- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001213809
In the last 90 days, Dyadic International Inc insiders filed 0 open-market purchases and 2 sales; 39 institutions reported holding it in 13F filings for Q2 2026, worth $4.14M in total; no superinvestor holds it.
Q2 2025 vs. Q1 2025
How the institutions holding Dyadic International Inc changed between Q1 2025 and Q2 2025.
All holders in Q2 2025All holders in Q1 2025
| Measure | Q1 2025 | Of which not filed for Q2 2025 | Q2 2025 | Change |
|---|---|---|---|---|
| Holders | 34 | 2 | 37 | +5 |
| Shares | 5.06M | 61.9K | 4.96M | −34.0K (−0.7%) |
| Value | $6.83M | $83.5K | $4.91M | −$1.83M (−27.2%) |
2 institutions that held it in Q1 2025 haven't filed for Q2 2025 yet. Not filing isn't selling, so the changes leave them out.
New holders (6)
Institutions that held Dyadic International Inc at the end of Q2 2025 but not at the end of Q1 2025.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| AlphaCore Capital LLC | 50,759 | $50.3K | 0.00% |
| Hancock Whitney Corp | 11,111 | $11.0K | 0.00% |
| Raymond James Financial Inc | 2,666 | $2.64K | 0.00% |
| Simplex Trading, LLC | 1,999 | $1.00K | 0.00% |
| Koesten, Hirschmann & Crabtree, INC. | 70 | $70 | 0.00% |
| Allworth Financial LP | 50 | $50 | 0.00% |
Sold out (1)
Institutions that held Dyadic International Inc at the end of Q1 2025 and filed for Q2 2025 without it.
| Institution | Shares, Q1 2025 | Value, Q1 2025 |
|---|---|---|
| Charles Schwab Investment Management Inc | 16,336 | $22.1K |
Not filed for Q2 2025 yet (2)
Institutions that held Dyadic International Inc at the end of Q1 2025 and haven't filed a 13F for Q2 2025. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q1 2025 | Value, Q1 2025 |
|---|---|---|
| Callan Capital, LLC | 50,759 | $68.5K |
| Sabal Trust CO | 11,111 | $15.0K |